EP1250142A4 - Multivalent electron active compositions and methods of making and using same - Google Patents
Multivalent electron active compositions and methods of making and using sameInfo
- Publication number
- EP1250142A4 EP1250142A4 EP00973747A EP00973747A EP1250142A4 EP 1250142 A4 EP1250142 A4 EP 1250142A4 EP 00973747 A EP00973747 A EP 00973747A EP 00973747 A EP00973747 A EP 00973747A EP 1250142 A4 EP1250142 A4 EP 1250142A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- making
- methods
- same
- active compositions
- electron active
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0208—Tissues; Wipes; Patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/245—Bismuth; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/32—Manganese; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/34—Copper; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/38—Silver; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/08—Antibacterial agents for leprosy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/04—Amoebicides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
- A61Q1/12—Face or body powders for grooming, adorning or absorbing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01G—COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
- C01G3/00—Compounds of copper
- C01G3/02—Oxides; Hydroxides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Applications Claiming Priority (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17479300P | 2000-01-06 | 2000-01-06 | |
US174793P | 2000-01-06 | ||
US18405300P | 2000-02-22 | 2000-02-22 | |
US184053P | 2000-02-22 | ||
US09/552,172 US6258385B1 (en) | 1999-04-22 | 2000-04-18 | Tetrasilver tetroxide treatment for skin conditions |
US552172 | 2000-04-18 | ||
US21450300P | 2000-06-28 | 2000-06-28 | |
US214503P | 2000-06-28 | ||
PCT/US2000/029116 WO2001049303A1 (en) | 2000-01-06 | 2000-10-20 | Multivalent electron active compositions and methods of making and using same |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1250142A1 EP1250142A1 (en) | 2002-10-23 |
EP1250142A4 true EP1250142A4 (en) | 2007-07-11 |
Family
ID=40458508
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP00975330A Withdrawn EP1246629A4 (en) | 2000-01-06 | 2000-10-20 | Methods of using electron active compounds for managing cancer |
EP00976613A Withdrawn EP1246630A4 (en) | 2000-01-06 | 2000-10-20 | Compositions and methods for facilitating skin growth and managing skin conditions |
EP00973747A Withdrawn EP1250142A4 (en) | 2000-01-06 | 2000-10-20 | Multivalent electron active compositions and methods of making and using same |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP00975330A Withdrawn EP1246629A4 (en) | 2000-01-06 | 2000-10-20 | Methods of using electron active compounds for managing cancer |
EP00976613A Withdrawn EP1246630A4 (en) | 2000-01-06 | 2000-10-20 | Compositions and methods for facilitating skin growth and managing skin conditions |
Country Status (8)
Country | Link |
---|---|
EP (3) | EP1246629A4 (en) |
JP (3) | JP2003519187A (en) |
AR (1) | AR029184A1 (en) |
AU (3) | AU784593B2 (en) |
CO (1) | CO5271678A1 (en) |
GT (1) | GT200000184A (en) |
TW (1) | TWI235661B (en) |
WO (3) | WO2001049302A1 (en) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9720061D0 (en) | 1997-09-19 | 1997-11-19 | Crosfield Joseph & Sons | Metal compounds as phosphate binders |
US20070208087A1 (en) | 2001-11-02 | 2007-09-06 | Sanders Virginia J | Compounds, compositions and methods for the treatment of inflammatory diseases |
US7635488B2 (en) | 2001-03-13 | 2009-12-22 | Dbv Technologies | Patches and uses thereof |
DE60210441T2 (en) | 2001-04-23 | 2006-11-16 | Nucryst Pharmaceuticals Corp., Fort Saskatchewan | MEDICAMENT OR PLASTER CONTAINS A METAL SUCH AS SILVER, GOLD, PLATINUM OR PALLADIUM AS AN ANTIMICROBIAL ACTIVE INGREDIENT AND ITS USE IN THE TREATMENT OF SKIN INFUSION |
TWI274585B (en) * | 2002-06-03 | 2007-03-01 | Nat Health Research Institutes | Pharmaceutical composition, kit, and packaged product for treating infection by a flaviviridae virus |
NZ543058A (en) * | 2003-03-24 | 2008-04-30 | Wellstat Biologics Corp | Newcastle disease virus administration |
US8048870B2 (en) * | 2005-01-11 | 2011-11-01 | Batarseh Kareem I | Apoptosis-inducing antineoplastic silver (I) coordination complexes |
NZ560448A (en) | 2005-02-16 | 2009-08-28 | Anacor Pharmaceuticals Inc | Boron-containing small molecules |
RU2008131324A (en) | 2005-12-30 | 2010-02-10 | Анакор Фармасьютикалз, Инк. (Us) | WOODEN SMALL MOLECULES |
MY157620A (en) | 2006-01-31 | 2016-06-30 | Cytochroma Dev Inc | A granular material of a solid water-soluble mixed metal compound capable of binding phosphate |
DK1988779T5 (en) | 2006-02-16 | 2016-10-10 | Anacor Pharmaceuticals Inc | SMALL boron MOLECULES AS ANTI-INFLAMMATORY AGENTS |
DE102006023394A1 (en) * | 2006-05-17 | 2007-11-22 | Gerd Prof. Wengler | Preparation and use of an antiviral chemotherapeutic agent which affects a host cell to block the replication of viruses in the cell |
GB0714670D0 (en) | 2007-07-27 | 2007-09-05 | Ineos Healthcare Ltd | Use |
GB0720220D0 (en) | 2007-10-16 | 2007-11-28 | Ineos Healthcare Ltd | Compound |
FR2924350B1 (en) | 2007-12-03 | 2010-08-13 | Dbv Tech | METHOD AND COMPOSITIONS FOR SKIN VACCINATION |
FR2924349B1 (en) | 2007-12-03 | 2010-01-01 | Dbv Tech | ALLERGEN DISENSIBILITY METHOD |
WO2009085651A1 (en) | 2007-12-20 | 2009-07-09 | Nucryst Pharmaceuticals Corp. | Metal carbonate particles for use in medicine and methods of making thereof |
RU2547441C2 (en) | 2008-03-06 | 2015-04-10 | Анакор Фармасьютикалз, Инк. | Boron-containing small molecules as anti-inflammatory agents |
JP5505679B2 (en) * | 2008-07-04 | 2014-05-28 | 和宏 小川 | Treatment or prevention of protozoan infections |
WO2010028005A1 (en) | 2008-09-04 | 2010-03-11 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules |
EP2348863A4 (en) | 2008-09-04 | 2012-03-07 | Anacor Pharmaceuticals Inc | Boron-containing small molecules |
GB2472126B (en) * | 2009-07-21 | 2011-08-03 | Aidance Skincare & Topical Solutions Llc | Topical Formulations Containing Silver (II) Oxide and Zinc Oxide |
GB0913525D0 (en) | 2009-08-03 | 2009-09-16 | Ineos Healthcare Ltd | Method |
AP4039A (en) | 2009-08-14 | 2017-02-28 | Daitao Chen | Boron-containing small molecules as antiprotozoal agents |
US9346834B2 (en) | 2009-10-20 | 2016-05-24 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules as antiprotozoal agents |
US8461134B2 (en) | 2009-11-11 | 2013-06-11 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules |
JP5570006B2 (en) | 2009-12-24 | 2014-08-13 | 国立大学法人 東京大学 | Virus inactivating agent |
US8716478B2 (en) | 2010-01-27 | 2014-05-06 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules |
GB201001779D0 (en) | 2010-02-04 | 2010-03-24 | Ineos Healthcare Ltd | Composition |
US8623911B2 (en) | 2010-03-19 | 2014-01-07 | Anacor Pharmaceuticals, Inc. | Boron-containing small molecules as anti-protozoal agent |
SG10201507032YA (en) | 2010-09-07 | 2015-10-29 | Anacor Pharmaceuticals Inc | Benzoxaborole derivatives for treating bacterial infections |
KR101657517B1 (en) * | 2010-12-22 | 2016-09-19 | 고쿠리츠다이가쿠호우진 도쿄다이가쿠 | Method for producing a visible light-responsive photocatalytic substance |
JP5824704B1 (en) * | 2014-07-20 | 2015-11-25 | 株式会社ライラック研究所 | Powder-like stagnation agent |
US11224227B2 (en) | 2015-02-08 | 2022-01-18 | Argaman Technologies Ltd. | Antimicrobial material comprising synergistic combinations of metal oxides |
WO2016125132A1 (en) * | 2015-02-08 | 2016-08-11 | Argaman Technologies Ltd. | Antimicrobial material comprising synergistic combinations of metal oxides |
JP6775927B2 (en) * | 2015-08-27 | 2020-10-28 | 住化エンバイロメンタルサイエンス株式会社 | Antibacterial composition |
EP3269357A1 (en) * | 2016-07-15 | 2018-01-17 | Universiteit Gent | Particles comprising metals and/or metal oxides for use to transform compounds in vivo |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2245351A2 (en) * | 1973-09-27 | 1975-04-25 | Agronomique Inst Nat Rech | Injectable trace element compns - as suspensions in oil for treating trace element deficiencies in animals |
US4994014A (en) * | 1988-07-26 | 1991-02-19 | Gordon Robert T | Process for treating diseased cells including the step of raising the subjects blood oxygen level |
DE19600744A1 (en) * | 1996-01-11 | 1997-07-17 | Werner Alois Prof Dipl Kaiser | Magnetic substance for local hyperthermic treatment of mainly small tumors |
DE19624426A1 (en) * | 1996-06-19 | 1998-01-02 | Christian Bergemann | Magnetic particle for transport of diagnostic or therapeutic agent |
DE19716732A1 (en) * | 1997-03-07 | 1998-09-17 | Max Delbrueck Centrum | Specific magnetosomes, processes for their preparation and their use |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2199459B1 (en) * | 1972-09-20 | 1975-08-08 | Agronomique Inst Nat Rech | |
DK313381A (en) * | 1980-07-24 | 1982-01-25 | Mckechnike Chemicals Ltd | REGULATED TRANSMISSION RELEASE |
US4574782A (en) * | 1981-11-16 | 1986-03-11 | Corning Glass Works | Radio frequency-induced hyperthermia for tumor therapy |
US4735796A (en) * | 1983-12-08 | 1988-04-05 | Gordon Robert T | Ferromagnetic, diamagnetic or paramagnetic particles useful in the diagnosis and treatment of disease |
US5612019A (en) * | 1988-12-19 | 1997-03-18 | Gordon, Deceased; David | Diagnosis and treatment of HIV viral infection using magnetic metal transferrin particles |
JPH0525051A (en) * | 1991-07-19 | 1993-02-02 | Meiji Seika Kaisha Ltd | Anemia-preventive/therapeutic agent |
US5336499A (en) * | 1992-01-10 | 1994-08-09 | Antelman Technologies, Ltd. | Molecular crystal device for pharmaceuticals |
DE59508069D1 (en) * | 1994-07-27 | 2000-04-27 | Herbert Pilgrimm | SUPERPARAMAGNETIC PARTICLES, METHOD FOR THE PRODUCTION AND USE THEREOF |
US5676977A (en) * | 1994-09-22 | 1997-10-14 | Antelman Technologies Ltd. | Method of curing AIDS with tetrasilver tetroxide molecular crystal devices |
JPH0912415A (en) * | 1995-06-29 | 1997-01-14 | Sekisui Chem Co Ltd | Antibacterial composition and antibacterial and bactericidal treatment |
JPH10218779A (en) * | 1997-02-10 | 1998-08-18 | Nippon Electric Glass Co Ltd | Hyperthermic material |
JP2000060976A (en) * | 1998-08-21 | 2000-02-29 | Hiroaki Koyanagi | Skin contact body used in skin contact with effective spot and route contining to spot of human body |
-
2000
- 2000-10-20 WO PCT/US2000/029115 patent/WO2001049302A1/en active Search and Examination
- 2000-10-20 JP JP2001549669A patent/JP2003519187A/en active Pending
- 2000-10-20 EP EP00975330A patent/EP1246629A4/en not_active Withdrawn
- 2000-10-20 AU AU14359/01A patent/AU784593B2/en not_active Ceased
- 2000-10-20 WO PCT/US2000/029116 patent/WO2001049303A1/en not_active Application Discontinuation
- 2000-10-20 WO PCT/US2000/029113 patent/WO2001049301A1/en not_active Application Discontinuation
- 2000-10-20 EP EP00976613A patent/EP1246630A4/en not_active Withdrawn
- 2000-10-20 AU AU13396/01A patent/AU784597B2/en not_active Ceased
- 2000-10-20 EP EP00973747A patent/EP1250142A4/en not_active Withdrawn
- 2000-10-20 JP JP2001549671A patent/JP2003519189A/en active Pending
- 2000-10-20 CO CO00080126A patent/CO5271678A1/en unknown
- 2000-10-20 AR ARP000105557A patent/AR029184A1/en unknown
- 2000-10-20 JP JP2001549670A patent/JP2003519188A/en active Pending
- 2000-10-20 AU AU12222/01A patent/AU1222201A/en not_active Abandoned
- 2000-10-23 TW TW089122108A patent/TWI235661B/en not_active IP Right Cessation
- 2000-10-23 GT GT200000184A patent/GT200000184A/en unknown
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2245351A2 (en) * | 1973-09-27 | 1975-04-25 | Agronomique Inst Nat Rech | Injectable trace element compns - as suspensions in oil for treating trace element deficiencies in animals |
US4994014A (en) * | 1988-07-26 | 1991-02-19 | Gordon Robert T | Process for treating diseased cells including the step of raising the subjects blood oxygen level |
DE19600744A1 (en) * | 1996-01-11 | 1997-07-17 | Werner Alois Prof Dipl Kaiser | Magnetic substance for local hyperthermic treatment of mainly small tumors |
DE19624426A1 (en) * | 1996-06-19 | 1998-01-02 | Christian Bergemann | Magnetic particle for transport of diagnostic or therapeutic agent |
DE19716732A1 (en) * | 1997-03-07 | 1998-09-17 | Max Delbrueck Centrum | Specific magnetosomes, processes for their preparation and their use |
Non-Patent Citations (1)
Title |
---|
See also references of WO0149303A1 * |
Also Published As
Publication number | Publication date |
---|---|
EP1246630A4 (en) | 2007-04-18 |
WO2001049303A1 (en) | 2001-07-12 |
AU784593B2 (en) | 2006-05-11 |
AU784597B2 (en) | 2006-05-11 |
AU1339601A (en) | 2001-07-16 |
TWI235661B (en) | 2005-07-11 |
EP1250142A1 (en) | 2002-10-23 |
GT200000184A (en) | 2002-04-16 |
WO2001049302A1 (en) | 2001-07-12 |
JP2003519187A (en) | 2003-06-17 |
AR029184A1 (en) | 2003-06-18 |
JP2003519188A (en) | 2003-06-17 |
AU1222201A (en) | 2001-07-16 |
AU1435901A (en) | 2001-07-16 |
JP2003519189A (en) | 2003-06-17 |
EP1246629A4 (en) | 2007-04-18 |
CO5271678A1 (en) | 2003-04-30 |
WO2001049301A1 (en) | 2001-07-12 |
EP1246630A1 (en) | 2002-10-09 |
EP1246629A1 (en) | 2002-10-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1250142A4 (en) | Multivalent electron active compositions and methods of making and using same | |
AU7362301A (en) | Bioadhesive compositions and methods of preparation and use | |
AU2001276048A1 (en) | Rapid-melt semi-solid compositions, methods of making same and methods of using same | |
AU2001279284A1 (en) | Rapid-melt semi-solid compositions, methods of making same and methods of using same | |
AU2001285020A1 (en) | P97-active agent conjugates and their methods of use | |
AU2778801A (en) | Antisense compositions and methods | |
EP1283707A4 (en) | Polymerizable compositions and methods of use | |
AU6118001A (en) | Combination therapeutic compositions and methods of use | |
AU8911801A (en) | Improved nanocomposite compositions and methods for making and using same | |
IL156119A0 (en) | Hollow cathode target and methods of making same | |
AU2002243277A1 (en) | Methods and compositions for encapsulating active agents | |
AU2001294920A1 (en) | Chrono delivery formulations and method of use thereof | |
AU2001281140A1 (en) | Anti-plasmodium compositions and methods of use | |
AU2001271753A1 (en) | Bat and method of manufacturing | |
PL347966A1 (en) | Electrode and method of making same | |
AU7501801A (en) | Composition and method for enhancing elasticity of tissue | |
AU2002221273A1 (en) | Delayed and sustained release formulations and method of use thereof | |
AU2001292667A1 (en) | Immunogenic composition of hepatitis c and methods of use thereof | |
HUP0303178A3 (en) | Methods and compositions for reducing the taste of pharmaceutically active agents | |
AU1931602A (en) | Cement-containing compositions and method of use | |
AU9567201A (en) | Vaccine composition and stabilisation method | |
AU2001295672A1 (en) | Vaccine composition and stabilisation method | |
AU2756301A (en) | Compositions comprising genome segments and methods of using the same | |
AU2001233086A1 (en) | Ceramidase compositions and methods based thereon | |
EP1263935A4 (en) | Scytonemin and methods of using thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20020801 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
AX | Request for extension of the european patent |
Free format text: AL;LT;LV;MK;RO;SI |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20070611 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20070503 |